Efficacy of the Acorn cardiac support device in animals with heart failure secondary to high rate pacing

Heart Failure Reviews

Volumn 10, Issue 2, 2005, Pages 117-123

  Power, John M ^a   Raman, Jai ^b   Byrne, Melissa J ^a   Alferness, Clif A ^c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF CHICAGO   (United States)

^c Acorn Cardiovascular Inc   (United States)

Author keywords

Cardiac support device; Heart failure; Ovine model; Passive ventricular constraint

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEVICE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART FUNCTION TEST; HEART HEMODYNAMICS; HEART LEFT VENTRICLE VOLUME; HEART OUTPUT; HEART PACING; MANOMETRY; MITRAL VALVE REGURGITATION; NONHUMAN; SHEEP; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TACHYCARDIA; TREADMILL EXERCISE;

ANIMALS; BLOOD PRESSURE; CARDIAC OUTPUT; DISEASE MODELS, ANIMAL; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; SEVERITY OF ILLNESS INDEX; SHEEP; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 27944474015     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-005-4639-8     Document Type: Article

References (9)

1. Stewart S, et al. Heart failure and the aging population: An increasing burden in the 21st century? Heart 2003;89(1):49-53. 10.1136/heart.89.1.49
2. Power JM, Tonkin AM. Large animal models of heart failure. Aust N Z J Med 1999;29(3):395-402. 10868511
3. Raman JS, et al. Ventricular constraint in severe heart failure halts decline in cardiovascular function associated with experimental dilated cardiomyopathy. Ann Thorac Surg 2003;76(1):141-147. 10.1016/ S0003-4975(03)00185-1
4. Power JM, et al. Passive ventricular constraint amends the course of heart failure: A study in an ovine model of dilated cardiomyopathy. Cardiovasc Res 1999;44(3):549-555. 10.1016/S0008-6363(99)00255-2
5. Byrne MJ, et al. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail 2002;8(2):108-115. 10.1054/jcaf.2002.32323
6. Power JM, et al. Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: A study in an ovine model of pacing induced dilated cardiomyopathy. Pacing Clin Electrophysiol 1998;21(8):1595-1600. 9725159
7. Power JM, et al. Susceptibility to atrial fibrillation: A study in an ovine model of pacing-induced early heart failure. J Cardiovasc Electrophysiol 1998;9(4):423-435. 9581958
8. Kaye DM, et al. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation. Circulation 2003;108(15):1795-1797. 10.1161/ 01.CIR.0000096051.23734.28
9. Byrne MJ, et al. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation 2004;110(19):3088-3092. 10.1161/01.CIR.0000146904.13677.E4